Opinion: China’s Covid-19 mRNA Vaccine Challenge

China plans to develop its own mRNA vaccine to control the production chain and lower the cost.

As the omicron variant of Covid-19 sweeps across China in the latest wave of the pandemic, the development of homegrown vaccines again stepped into the spotlight.

Since March, a rising tide of virus flare-ups has forced a number of Chinese cities into lockdown, including the Asian financial hub Shanghai. As China fights its worst outbreak since Wuhan, progress by domestic drugmakers in the development of Covid-19 vaccines based on the advanced mRNA technology made headlines.

You've accessed an article available only to subscribers

Subscribe today for just $.99.

VIEW OPTIONS

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Ice Creams Unite to Cool the People

PODCAST

Caixin China Biz Roundup: Beijing Makes Vaccines Mandatory for Crowded Public Spaces

MOST POPULAR

1: In Depth: How Chinese Factories Are Finding Their Way to Mexico

2: In Depth: How SoftBank Wrestled Back Control of Arm China

3: Boeing Pain From U.S.-China Trade War Seen in Airbus Buying Bonanza

4: China’s Plunging Land Sales Threaten Local Government Coffers

5: Chinese Tech Giants Cut Back on Office Space in Shenzhen